Blinatumomab gains European approval in childrenSeptember 4, 2018Leukemia, Myelodysplasia, Transplantation
FDA fast-tracks CX-01 for newly diagnosed AMLSeptember 4, 2018Leukemia, Myelodysplasia, Transplantation
European Commission approves first CAR T-cell therapiesAugust 28, 2018PediatricsLeukemia, Myelodysplasia, TransplantationImmunotherapy
Combo treatment yields MRD-negative remissions in CLLAugust 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
FDA grants orphan designation to DHODH inhibitor for AMLAugust 21, 2018Leukemia, Myelodysplasia, Transplantation
FDA puts partial hold on trial of vascular agent for AML, MDSAugust 20, 2018Leukemia, Myelodysplasia, Transplantation
Lenalidomide best option for myeloma maintenance therapyAugust 15, 2018Leukemia, Myelodysplasia, Transplantation
New chronic lymphocytic leukemia guidelines from the UKAugust 8, 2018Leukemia, Myelodysplasia, Transplantation
Vadastuximab talirine gives big boost to AML remissionAugust 2, 2018Leukemia, Myelodysplasia, Transplantation
Intrathecal methotrexate dosing in acute leukemia falls shortJuly 26, 2018Leukemia, Myelodysplasia, Transplantation
Myeloma frailty index predicts survival based on biological ageJuly 25, 2018Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
FDA approves Nivestym, second biosimilar to NeupogenJuly 20, 2018Patient & Survivor CareLeukemia, Myelodysplasia, Transplantation
FDA approves IDH1 inhibitor for relapsed/refractory AMLJuly 20, 2018Leukemia, Myelodysplasia, Transplantation
Ibrutinib stacks up well on safety in pooled analysisJuly 20, 2018Leukemia, Myelodysplasia, Transplantation
Lab results may help predict complications in ALL treatmentJuly 17, 2018Leukemia, Myelodysplasia, Transplantation
